In addition to STAT3, these included SMARCA2, a tumor suppressor involved in various cancers, SOCS1, a STAT-inhibitor, DNMT3A, with known somatic mutations in the context of clonal hematopoiesis and PPP3CA encoding calcineurin-A, involved in T-cell receptor signaling. Here, SMARCA2 is linked to cancer.